Literature DB >> 24554979

Comparison of 8, 10, 12, 16, 20 cores prostate biopsies in the determination of prostate cancer and the importance of prostate volume.

Cavit Ceylan1, Omer Gokhan Doluoglu2, Erdogan Aglamis3, Ozkan Baytok1.   

Abstract

INTRODUCTION: In this study, we evaluate the relationship between increasing core numbers and cancer detection rate.
METHODS: We included 1120 patients with prostate-specific antigen levels ≤20 ng/mL and/or suspicious digital rectal examination findings in this study. All patients had a first-time prostate biopsy and 8, 10, 12, 16, and 20 core biopsies were taken and examined in different groups during the study. Multiple logistic regression analysis was made to reach the factor affecting the cancer detection rate between the patients with and without cancer. A p < 0.05 was considered statistically significant.
RESULTS: Out of 1120 patients, 221 (19.7%) had prostate cancer. Again of the total 1120 patients, 8 core biopsies were taken from 229 (20.4%); 10 core biopsies from 473 (42.2%); 12 core biopsies from 100 (8.9%); 16 core biopsies from 140 (12.5%); and 20 core biopsies from 178 (15.9%) patients. The increase in the core number increased the cancer detection rate by 1.06 times (p = 0.008).
CONCLUSIONS: As long as prostate volume increases, increasing the core number elevates the cancer detection rate. Thus, the rate of missed cancer will be reduced and the rates of unnecessary repetitive biopsy decreases.

Entities:  

Year:  2014        PMID: 24554979      PMCID: PMC3926931          DOI: 10.5489/cuaj.510

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  22 in total

1.  The relationship of prostate gland volume to extended needle biopsy on prostate cancer detection.

Authors:  Jean O Ung; Ignacio F San Francisco; Meredith M Regan; William C DeWolf; Aria F Olumi
Journal:  J Urol       Date:  2003-01       Impact factor: 7.450

2.  Transperineal ultrasound-guided 12-core systematic biopsy of the prostate for patients with a prostate-specific antigen level of 2.5-20 ng/ml in Japan.

Authors:  Shinya Yamamoto; Ujin Kin; Kazuyoshi Nakamura; Masaaki Hamano; Yasuyo Nishikawa; Toshinao Takenouchi; Masayuki Maruoka
Journal:  Int J Clin Oncol       Date:  2005-04       Impact factor: 3.402

3.  Extensive biopsy using a combined transperineal and transrectal approach to improve prostate cancer detection.

Authors:  Masami Watanabe; Toshihide Hayashi; Tomoyasu Tsushima; Shin Irie; Tetsuzo Kaneshige; Hiromi Kumon
Journal:  Int J Urol       Date:  2005-11       Impact factor: 3.369

4.  Saturation technique does not improve cancer detection as an initial prostate biopsy strategy.

Authors:  J Stephen Jones; Amit Patel; Lynn Schoenfield; John C Rabets; Craig D Zippe; Cristina Magi-Galluzzi
Journal:  J Urol       Date:  2006-02       Impact factor: 7.450

5.  Comparison of 6- and 12-core prostate biopsy in Taiwanese men: impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection.

Authors:  I-Ni Chiang; Shang-Jen Chang; Yeong-Shiau Pu; Kuo-How Huang; Hong-Jen Yu; Chao-Yaun Huang
Journal:  Urol Int       Date:  2009-05-11       Impact factor: 2.089

6.  Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy.

Authors:  Herb Singh; Eduardo I Canto; Shahrokh F Shariat; Dov Kadmon; Brian J Miles; Thomas M Wheeler; Kevin M Slawin
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

7.  The effect of prostate volume on the yield of needle biopsy.

Authors:  J L Letran; G E Meyer; F R Loberiza; M K Brawer
Journal:  J Urol       Date:  1998-11       Impact factor: 7.450

8.  Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.

Authors:  Guillaume Guichard; Stéphane Larré; Andrea Gallina; Adi Lazar; Hugo Faucon; Stéphanie Chemama; Yves Allory; Jean-Jacques Patard; Dimitri Vordos; Andras Hoznek; René Yiou; Laurent Salomon; Claude Clément Abbou; Alexandre de la Taille
Journal:  Eur Urol       Date:  2007-03-13       Impact factor: 20.096

9.  An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer.

Authors:  Saadettin Yilmaz Eskicorapci; Dilek Ertoy Baydar; Cem Akbal; Mustafa Sofikerim; Mert Günay; Sinan Ekici; Haluk Ozen
Journal:  Eur Urol       Date:  2004-04       Impact factor: 20.096

10.  Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

Authors:  K K Hodge; J E McNeal; M K Terris; T A Stamey
Journal:  J Urol       Date:  1989-07       Impact factor: 7.450

View more
  8 in total

1.  Does the prostate volume always effect cancer detection rate in prostate biopsy? Additional role of prostate-specific antigen levels: A retrospective analysis of 2079 patients.

Authors:  Engin Kandıralı; Mustafa Zafer Temiz; Aykut Çolakerol; Emrah Yürük; Atilla Semerciöz; Ahmet Yaser Müslümanoğlu
Journal:  Turk J Urol       Date:  2018-03-16

2.  Six-core versus twelve-core prostate biopsy: a retrospective study comparing accuracy, oncological outcomes and safety.

Authors:  W Mohammed; N F Davis; S Elamin; P Ahern; C M Brady; P Sweeney
Journal:  Ir J Med Sci       Date:  2015-03-19       Impact factor: 1.568

3.  Relative Contribution of Sampling and Grading to the Quality of Prostate Biopsy: Results from a Single High-volume Institution.

Authors:  Carlo Andrea Bravi; Emily Vertosick; Amy Tin; Simone Scuderi; Giuseppe Fallara; Giuseppe Rosiello; Elio Mazzone; Marco Bandini; Giorgio Gandaglia; Nicola Fossati; Massimo Freschi; Rodolfo Montironi; Alberto Briganti; Francesco Montorsi; Andrew Vickers
Journal:  Eur Urol Oncol       Date:  2018-11-24

4.  3-Tesla magnetic resonance imaging improves the prostate cancer detection rate in transrectral ultrasound-guided biopsy.

Authors:  Jie Chen; Xiao-Lei Yi; Li-Xin Jiang; Ren Wang; Jun-Gong Zhao; Yue-Hua Li; Bing Hu
Journal:  Exp Ther Med       Date:  2014-11-11       Impact factor: 2.447

5.  What is the ideal core number for ultrasound-guided prostate biopsy?

Authors:  Renato Caretta Chambó; Fábio Hissachi Tsuji; Flávio de Oliveira Lima; Hamilto Akihissa Yamamoto; Carlos Márcio Nóbrega de Jesus
Journal:  Korean J Urol       Date:  2014-11-04

Review 6.  The role of MRI in prostate cancer active surveillance.

Authors:  Linda M Johnson; Peter L Choyke; William D Figg; Baris Turkbey
Journal:  Biomed Res Int       Date:  2014-11-30       Impact factor: 3.411

7.  A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer.

Authors:  Farhana Matin; Varinder Jeet; Leire Moya; Luke A Selth; Suzanne Chambers; Judith A Clements; Jyotsna Batra
Journal:  Sci Rep       Date:  2018-04-27       Impact factor: 4.379

8.  Diagnostic significance of reassessment of prostate biopsy specimens by experienced urological pathologists at a high-volume institution.

Authors:  Yoichiro Okubo; Yayoi Yamamoto; Shinya Sato; Emi Yoshioka; Masaki Suzuki; Kota Washimi; Kimito Osaka; Takahisa Suzuki; Tomoyuki Yokose; Takeshi Kishida; Yohei Miyagi
Journal:  Virchows Arch       Date:  2022-01-11       Impact factor: 4.535

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.